Unravelling drug-drug interactions in pigs: Induction of hepatic cytochrome P450 1A (CYP1A) metabolism after the in-feed medication with the anthelmintic fenbendazole

被引:0
|
作者
Ichinose, Paula [1 ,2 ]
Miro, Maria Victoria [1 ,2 ]
Larsen, Karen [1 ,2 ]
Lifschitz, Adrian [1 ,2 ]
Virkel, Guillermo [1 ,2 ]
机构
[1] Univ Nacl Ctr Prov Buenos Aires UNCPBA, Fac Ciencias Vet, Tandil, Buenos Aires, Argentina
[2] UNCPBA, Ctr Invest Vet Tandil CIVETAN, CICPBA, CONICET, Tandil, Buenos Aires, Argentina
关键词
Fenbendazole; Cytochrome P450; Enzyme induction; Aflatoxin B1; Liver; Pigs; ALPHA-NAPHTHOFLAVONE; AFLATOXIN B-1; BIOTRANSFORMATION ENZYMES; LIQUID-CHROMATOGRAPHY; LIVER; EXPRESSION; ACTIVATION; SWINE; SULFOXIDATION; FLUBENDAZOLE;
D O I
10.1016/j.rvsc.2023.105113
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The anthelmintic fenbendazole (FBZ) undergoes hepatic S-oxygenation by monooxygenases belonging to the cytochrome P450 (CYP) and flavin-monooxygenase (FMO) families. The in-feed medication with FBZ induced CYP1A-dependent metabolism in pig liver. This fact may alter the metabolism of the anthelmintic itself, and of CYP1A substrates like aflatoxin B1 (AFB1). This work evaluated the effect of the in-feed administration of FBZ on CYP1A-dependent metabolism, on its own pattern of hepatic S-oxygenation, and on the metabolism of AFB1. Landrace piglets remained untreated (n = 5) or received a pre-mix of FBZ (n = 6) in feed for 9 days. Pigs were slaughtered for preparation of liver microsomes used for: CYP content determination; monitoring the CYP1A-dependent enzyme activities, 7-ethoxyresorufin O-deethylase (EROD) and 7-methoxyresorufin O-demethylase (MROD); measurement of FBZ (50 mu M) S-oxygenation, and AFB1 (16 nM) disappearance from the incubation medium. In microsomes of FBZ-treated animals, EROD and MROD increased 19-fold (p = 0.002) and 14-fold (p = 0.003), respectively. An enhanced (3-fold, p = 0.004) participation of the CYP pathway in FBZ S-oxygenation was observed in the liver of piglets treated with the anthelmintic (210 +/- 69 pmol/min.nmol CYP) compared to untreated animals (68 +/- 34 pmol/min.nmol CYP). AFB1 metabolism was 93% higher (p = 0.009) in the liver of FBZ-treated compared to untreated pigs. Positive and significant (p < 0.05) correlations were observed between CYP1A-dependent enzyme activities and FBZ or AFB1 metabolism. The sustained administration of FBZ caused an auto-induction of the CYP1A-dependent S-oxygenation of this anthelmintic. The CYP1A induction triggered by the anthelmintic could amplify the production of AFB1 metabolites in pig liver, including the hepatotoxic AFB1-derived epoxide.++
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Drug-drug interactions and metabolism in cytochrome P450 2C knockout mice: Application to troleandomycin and midazolam
    Grimsley, Aidan
    Gallagher, Richard
    Hutchison, Michael
    Pickup, Kathryn
    Wilson, Ian D.
    Samuelsson, Kristin
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (04) : 529 - 538
  • [22] CDNA cloning and expression of a cytochrome P450 1A (CYP1A) gene from the hermaphroditic fish Rivulus marmoratus
    Lee, YM
    Williams, TD
    Jung, SO
    Lee, JS
    MARINE POLLUTION BULLETIN, 2005, 51 (8-12) : 769 - 775
  • [23] Biotransformation of the Mycotoxin Enniatin B1 by CYP P450 3A4 and Potential for Drug-Drug Interactions
    Ivanova, Lada
    Denisov, Ilia G.
    Grinkova, Yelena, V
    Sligar, Stephen G.
    Faeste, Christiane K.
    METABOLITES, 2019, 9 (08)
  • [24] Studies of anthelminthic benzimidazole derivatives on cytochrome P450 1A (CYP1A) dependent detoxification mechanism in Labeo rohita
    Dar, Showkat Ahmad
    Gora, Adnan Hussain
    Bhat, Irfan Ahmad
    Kumar, Sarvendra
    Srivastava, P. P.
    Muralidhar, P. A.
    Gupta, Subodh
    AQUACULTURE, 2017, 481 : 79 - 84
  • [25] HEPATIC-MICROSOMAL METABOLISM OF THE ANTHELMINTIC BENZIMIDAZOLE FENBENDAZOLE - ENHANCED INHIBITION OF CYTOCHROME-P450 REACTIONS BY OXIDIZED METABOLITES OF THE DRUG
    MURRAY, M
    HUDSON, AM
    YASSA, V
    CHEMICAL RESEARCH IN TOXICOLOGY, 1992, 5 (01) : 60 - 66
  • [26] In Vitro Evaluation of Potential Drug-Drug Interactions with Ticagrelor: Cytochrome P450 Reaction Phenotyping, Inhibition, Induction, and Differential Kinetics
    Zhou, Diansong
    Andersson, Tommy B.
    Grimm, Scott W.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (04) : 703 - 710
  • [27] Clinical Drug-Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib
    Morcos, Peter N.
    Cleary, Yumi
    Guerini, Elena
    Dall, Georgina
    Bogman, Katrijn
    De Petris, Luigi
    Viteri, Santiago
    Bordogna, Walter
    Yu, Li
    Martin-Facklam, Meret
    Phipps, Alex
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (03): : 280 - 291
  • [28] CYTOCHROME P450 ENZYME MEDIATED HERBAL DRUG INTERACTIONS (PART 1)
    Wanwimolruk, Sompon
    Prachayasittikul, Virapong
    EXCLI JOURNAL, 2014, 13 : 347 - 391
  • [29] Impact of parallel pathways of drug elimination and multiple cytochrome P450 involvement on drug-drug interactions: CYP2D6 paradigm
    Ito, K
    Hallifax, D
    Obach, RS
    Houston, JB
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (06) : 837 - 844
  • [30] Drug-drug interactions in the metabolism of imidafenacin: Role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes
    Kanayama, N.
    Kanari, C.
    Masuda, Y.
    Ohmori, S.
    Ooie, T.
    XENOBIOTICA, 2007, 37 (02) : 139 - 154